AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Molecule to Medicine Data, Technology Stack, and Enterprise Applications
PaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Amazon Web Services (AWS) Legacy Amazon Lambda Apps Development PaaS n/a 2024 2024
ITSM
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Freshworks Legacy Freshservice IT Service Management ITSM n/a 2024 2024
IT Decision Makers and Key Stakeholders at Molecule to Medicine
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Molecule to Medicine Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Molecule to Medicine Technographics

Molecule to Medicine is a Life Sciences organization based in United Kingdom, with around 85 employees and annual revenues of $8.0 million.

Molecule to Medicine operates a diverse technology stack with applications such as Amazon EC2, Amazon Lambda and Freshservice, covering areas like Application Hosting and Computing Services, Apps Development and IT Service Management.

Molecule to Medicine has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Amazon Web Services (AWS) and Freshworks.

Molecule to Medicine recently adopted applications including Amazon EC2 in 2024, GoDaddy in 2024 and Amazon CloudFront in 2024, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Molecule to Medicine’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Molecule to Medicine’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Molecule to Medicine technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.